Company intelligence / Profile preview

Grupo Collins

Zapopan, Jalisco, Mexico

Ownership: Private
Employees: ~1700
Development stage: Other

Overview

Grupo Collins manufactures over 300 brands with around 200 regulatory registrations. Its generics division offers more than 119 products in at least fifteen therapeutic classes. The company also produces herbal medicines and natural products as well as a veterinary line serving multiple animal species. No clinical trial or investigational-stage programs are reported; all offerings appear to be commercialized.

Therapeutic areas: OtherMetabolic Disorders
Modalities: Small moleculeHerbal/natural product therapyBiologicGeneric drugsFood/agricultural products
Industry: Biotech

Beyond the preview

Go deeper on Grupo Collins.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grupo Collins.

Explore the full profile